Diabetes treatments have saved many lives, but in older patients with multiple medical conditions, aggressively controlling blood sugar with insulin and sulfonylurea drugs, could lead to over-treatment and hypoglycemia (low blood sugar), according to new research by Yale School of Medicine researchers. Published in the Jan. 12 issue of JAMA Internal Medicine, the study found […]
The numbers are sobering: While the U.S. Centers for Disease Control and Prevention (CDC) estimates that 3.2 million Americans are currently infected with the Hepatitis C virus (HCV), the World Health Organization (WHO) further estimates that a staggering 130–150 million people globally have a chronic HCV infection and that 350,000 to 500,000 people die each […]
Queen’s University assistant professor Pendar Farahani (Department of Medicine and Department of Public Health Sciences) is advocating the use of gender-based treatment for mitigating the cardiovascular risk factors related to diabetes. Research has shown women with Type 2 diabetes and high cholesterol are less likely than their male peers to reach treatment goals to lower […]
CHICAGO — In an aggressive disease known for poor response rates, researchers from The University of Texas MD Anderson Cancer Center found patients with advanced colorectal cancer responded well to a combination therapy of the drugs vermurafenib, cetuximab and irinotecan. The Phase I trial, presented Saturday, May 31 in a poster discussion at the American Society of […]